ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Biogen Pharmachem Industries Limited submitted its 31st Annual Report for the financial year 2025-26. The Annual General Meeting is scheduled for September 29, 2026.
Biogen Pharmachem Industries Ltd has issued a notice for its 31st Annual General Meeting scheduled for September 29, 2026. The meeting will be held via video conferencing.
Biogen Pharmachem Industries Limited has reported no unutilised funds from any prior capital raises, including public issues, rights issues, or preferential allotments, as of June 2026.
Biogen Pharmachem Industries Ltd reported revenue from operations of ₹0.4 Cr (-73.3% YoY) and net profit of ₹0.2 Cr (-84.6% YoY) for Q1 FY27.
Biogen Pharmachem Industries Limited scheduled a Board meeting for August 5, 2026. The meeting will consider and approve financial results for the quarter ended June 30, 2026.